May FDA panel to discuss Ebola vax development; U.S., Indian scientists debate swine flu strain's virulence;

> An FDA panel will discuss Ebola vaccine development on May 12. Report

> Scientists in the U.S. and India are battling over the virulence of the latter country's swine flu strain. More

> Immunovaccine is seeking approval to have its common shares trade on the OTCQX(R) Best Marketplace. Release

> NIH's National Institute of Allergy and Infectious Diseases (NIAID) has awarded $16 million to a University of Pennsylvania-led group to develop synthetic DNA vaccines to fight HIV. More

> A new vaccine from China's Yisheng Biopharma for post-exposure treatment of rabies infection has entered human clinical trials. Report

And Finally... India's government is launching a 15-day media campaign to educate the masses on immunization. More

Suggested Articles

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.

Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.

Experts are pushing for the introduction of J&J's vaccine in the response to the Ebola outbreak in the Democratic Republic of Congo.